Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 019710
Company: LIEBEL-FLARSHEIM
Company: LIEBEL-FLARSHEIM
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
OPTIRAY 160 | IOVERSOL | 34% | INJECTABLE;INJECTION | Discontinued | None | No | No |
OPTIRAY 240 | IOVERSOL | 51% | INJECTABLE;INJECTION | Discontinued | None | Yes | No |
OPTIRAY 300 | IOVERSOL | 64% | INJECTABLE;INJECTION | Prescription | None | Yes | Yes |
OPTIRAY 320 | IOVERSOL | 68% | INJECTABLE;INJECTION | Prescription | None | Yes | Yes |
OPTIRAY 350 | IOVERSOL | 74% | INJECTABLE;INJECTION | Prescription | None | Yes | Yes |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
05/04/2022 | SUPPL-64 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019710Orig1s064lbl.pdf | |
05/04/2022 | SUPPL-64 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019710Orig1s064lbl.pdf | |
02/18/2022 | SUPPL-65 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019710s065,020923s028lbl.pdf | |
01/23/2020 | SUPPL-58 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019710s058lbl.pdf | |
04/26/2017 | SUPPL-54 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019710s054,020923s019lbl.pdf | |
04/05/2017 | SUPPL-55 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019710s055lbl.pdf | |
08/12/2016 | SUPPL-39 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019710s039,020923s009lbl.pdf | |
07/06/2015 | SUPPL-52 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019710s052,020923s018lbl.pdf |